| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |